Leucine-rich Alpha 2 Glycoprotein-1 (LRG1), Human Plasma

PRODUCT NUMBER:

Buy direct from manufacturer.
Bulk Qty Available.

MW: 50,000 Da
Extinction Coefficient: 0.70

Lyophilized from 20mM Tris, 20 mM NaCl, pH 7.5

In normal plasma LRG1 has a concentration of 21-50 ug/ml. It is an acute phase protein with levels elevated in patients with bacterial infections; interestingly, during the inflammatory response, LRG1 levels are not correlated with CRP levels.

LRG1 binds cytochrome c, an initiator/amplifier of programmed cell death (apoptosis), and by binding cytochrome c, is thought to play a role in cell survival.

LRG1 is a biomarker associated with several cancers, including non-small cell lung cancer, colorectal cancer, and pancreatic cancer. Recent studies have shown it is three-fold more abundant in ovarian cancer serum compared to non-cancer control serum. LRG1 levels are only moderately correlated with CA125 levels.

Elevated levels of LRG1 in cerebral spinal fluid are being studied as markers for the early diagnosis of Parkinson's disease and progressive supranuclear palsy.

Storage: <= -20°C

Purity: >=95% by SDS-PAGE. Positive reaction to anti-LRG1 on Western Blot.

Prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA-required tests.

Athens Research & Technology products are laboratory reagents and are not to be administered to humans or used for any drug purpose. For research or further manufacturing use only.